Low-molecular-weight heparin for initial treatment of venous thromboembolism

Am Fam Physician. 2005 Jul 1;72(1):75-6.

Author

Dan Brewer¹

Affiliation

¹ Department of Family Medicine, University of Tennessee, Knoxville 37920, USA. dbrewer2@utk.edu

PMID: 16035683

No abstract available

Publication types

Review

MeSH terms

Acute Disease
Aged
Anticoagulants / adverse effects
Anticoagulants / economics
Anticoagulants / therapeutic use*
Cost-Benefit Analysis
Drug Costs / statistics & numerical data
Evidence-Based Medicine
Female
Femoral Vein
Heparin, Low-Molecular-Weight / adverse effects
Heparin, Low-Molecular-Weight / economics
Heparin, Low-Molecular-Weight / therapeutic use*
Humans
Patient Selection
Randomized Controlled Trials as Topic
Research Design
Safety
Thromboembolism / diagnosis
Thromboembolism / drug therapy*
Treatment Outcome
Venous Thrombosis / diagnosis
Venous Thrombosis / drug therapy*

Substances

Anticoagulants
Heparin, Low-Molecular-Weight